Complementary to these preclinical studies, compassionate-use taurine supplementation in siblings with SLC6A6 variants (encoding the taurine transporter) demonstrated reversal of cardiomyopathy and arrest of retinal degeneration. The gene discussed is SLC6A6; the disease is cardiomyopathy.